Posted inBiotechnology
‘The only thing that saves us is data’: Allogeneic CAR-T biotechs fight for relevance as industry moves on
Ever since 6-year-old Emily Whitehead became the first patient to receive CAR-T cell therapy in 2012, when T cells were…





